Apathy Mechanisms Differ Between Alzheimer's and Parkinson's Disease

The Clinical Challenge of Motivational Loss in Neurodegeneration

Apathy is among the most prevalent neuropsychiatric symptoms in neurodegenerative disorders, affecting approximately 40 percent of patients with Parkinson's disease and over half of those with Alzheimer's disease [1, 2]. This persistent loss of motivation is clinically distinct from depression and is associated with accelerated cognitive decline, increased caregiver burden, and higher rates of functional disability [1, 3]. Despite its clinical impact, current pharmacological treatments, including cholinesterase inhibitors and stimulants, often yield inconsistent results across different patient populations [4]. Standardized assessment tools like the Apathy Evaluation Scale help identify the syndrome, yet they often fail to capture the specific computational deficits in how patients weigh rewards against physical effort [5]. To address this gap, researchers recently investigated whether the underlying mechanisms of motivational loss are shared across these conditions or if they represent distinct, disease-specific pathways, raising the prospect that future diagnostic tools could match patients to targeted interventions based on their unique neurobiological profiles.

Quantifying Effort and Reward in the Apple-Gathering Task

To investigate the computational underpinnings of motivational loss, researchers recruited a clinical cohort consisting of 37 patients with amnestic mild cognitive impairment and probable Alzheimer's disease (aMCI/pAD) alongside 51 patients with Parkinson's disease who were undergoing work-up for deep brain stimulation. These clinical groups were compared against 21 healthy controls to establish a baseline for normal motivational processing. To ensure the findings correlated with real-world clinical presentations, the study utilized caregiver-rated apathy scores for all participants, providing a standardized measure of daily motivational deficits. The primary experimental tool was the apple-gathering task, a physical effort-based decision-making paradigm. During this task, participants were presented with various offers and had to decide whether to accept or reject them based on two variables: the potential reward (represented by the number of apples) and the physical effort required to obtain them (which necessitated squeezing a handheld dynamometer at specific pressure levels). This design allowed the researchers to isolate how patients weigh the cost of physical exertion against the incentive of a reward, a core computation in the initiation of goal-directed behavior. Beyond simple choice percentages, the researchers analyzed reaction times and decision patterns using drift diffusion modeling (a statistical method that uncovers latent cognitive processes by simulating how evidence accumulates in the brain before a decision is made). This computational approach allowed the team to identify the hidden steps in the decision-making process that are not visible through standard clinical observation. By applying this model, the study could differentiate whether a patient's failure to engage was driven by a diminished response to reward or an exaggerated sensitivity to the effort required, providing a granular view of the internal evidence-gathering process that precedes physical action.

Divergent Responses to Physical Effort Costs

The researchers utilized a model-free analysis (a direct assessment of the raw behavioral choices made during the task without applying complex mathematical simulations) to identify how reward and effort levels influenced patient decisions. This analysis revealed that apathy in both the aMCI/pAD and Parkinson's disease groups was associated with reduced incentivization by lower rewards. For clinicians, this suggests a shared motivational deficit across these neurodegenerative conditions where small incentives fail to trigger the necessary goal-directed behavior. Regardless of the primary diagnosis, patients with higher apathy scores required larger potential rewards to engage in the physical task, indicating a common blunting of reward processing for low-value outcomes. While reward processing showed similarities, the study identified a stark divergence in how each disease group perceived the cost of physical exertion. In the Parkinson's disease cohort, apathy was associated with increased sensitivity to high effort costs, meaning these patients were significantly more likely to reject offers as the physical demand increased. Conversely, apathy in the aMCI/pAD group was associated with reduced sensitivity to effort, a finding that suggests these patients fail to appropriately weigh the difficulty of a task against its potential benefit. This distinction is clinically significant. While a patient with Parkinson's disease may avoid a task because it feels too physically demanding, a patient with Alzheimer's disease might fail to engage because they are not properly processing the effort-to-reward ratio at all, suggesting that behavioral interventions for apathy may need to be tailored specifically to the underlying diagnosis.

Neural Signatures of Decision Bias and White Matter Integrity

To identify the specific mechanisms driving motivational deficits, the researchers employed linear regression models to examine associations between apathy, diagnosis, and latent cognitive processes (the internal mental computations that precede an observable choice). These processes were further analyzed using drift diffusion modeling, a mathematical framework that decomposes decision-making into distinct parameters such as the rate of information accumulation and initial bias. The analysis revealed that an increased drift rate to reject offers as a function of changing effort levels was significantly associated with lower motivation in Parkinson's disease. This finding indicates that as effort requirements increased, patients with Parkinson's disease and high apathy scores accumulated evidence toward rejecting the task more rapidly than their peers. Notably, this association between increased drift rate to reject offers and lower motivation was not found in the aMCI/pAD group, suggesting that the computational drivers of apathy in Alzheimer's disease stem from different cognitive impairments. The study further investigated the biological basis of these findings using linear mixed models to examine associations between latent cognitive processes and brain structure and connectivity in a priori regions (specific brain areas identified in advance as likely candidates for involvement). In the Parkinson's disease cohort, the increased drift rate to reject offers was associated with lower fractional anisotropy (a measure of white matter integrity and connectivity) in the pathways linking the dorsal anterior cingulate cortex and the striatum. For the clinician, this provides a structural explanation for apathy: the degradation of white matter tracts between the region responsible for effort-cost evaluation and the region responsible for action selection impairs the ability to initiate effortful behavior. Furthermore, across all participants regardless of diagnosis, apathy was associated with a bias towards rejecting offers, captured by the decision bias parameter. This general tendency to favor inaction was associated with increased functional connectivity in the dorsal attention network, suggesting that a common neural signature of apathy involves altered communication within the brain's top-down attentional systems. Ultimately, these findings indicate that while apathy presents similarly at the bedside, its underlying neural and computational drivers differ significantly by disease, underscoring the need for diagnosis-specific therapeutic strategies.

References

1. Brok MGD, Dalen JWV, Gool WAV, Charante EPMV, Bie RMD, Richard E. Apathy in Parkinson's disease: A systematic review and meta‐analysis. Movement Disorders. 2015. doi:10.1002/mds.26208

2. Leung DKY, Chan WC, Spector A, Wong GHY. Prevalence of depression, anxiety, and apathy symptoms across dementia stages: A systematic review and meta-analysis.. International journal of geriatric psychiatry. 2021. doi:10.1002/gps.5556

3. Azocar I, Rapaport P, Burton A, Meisel G, Orgeta V. Risk factors for apathy in Alzheimer's disease: A systematic review of longitudinal evidence.. Ageing research reviews. 2022. doi:10.1016/j.arr.2022.101672

4. Theleritis C, Siarkos K, Politis A, Smyrnis N, Papageorgiou C, Politis AM. A Systematic Review of Pharmacological Interventions for Apathy in Aging Neurocognitive Disorders.. Brain sciences. 2023. doi:10.3390/brainsci13071061

5. Mohammad D, Ellis C, Rau A, et al. Psychometric Properties of Apathy Scales in Dementia: A Systematic Review.. Journal of Alzheimer's disease : JAD. 2018. doi:10.3233/JAD-180485